These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 16186087)

  • 1. Monitoring people at risk of drinking by a rapid urinary ethyl glucuronide test.
    Fucci N; Gili A; Aroni K; Bacci M; Carletti P; Pascali VL; Gambelunghe C
    Interdiscip Toxicol; 2017 Dec; 10(4):155-162. PubMed ID: 30147423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using routine laboratory tests to detect heavy drinking in the general population.
    Harasymiw J; Seaberg J; Bean P
    J Addict Dis; 2006; 25(2):59-63. PubMed ID: 16785221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The early detection of alcohol consumption (EDAC) score in the identification of Heavy and at-risk drinkers from routine blood tests.
    Harasymiw JW; Vinson DC; Bean P
    J Addict Dis; 2000; 19(3):43-59. PubMed ID: 11076119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new century approach for alcohol screen in the insurance industry.
    Bean P; Kleaver E; Roberts B; Harasymiw J
    J Insur Med; 2001; 33(2):183-8. PubMed ID: 11510515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic accuracy of carbohydrate-deficient transferrin, sialic acid and commonly used markers of alcohol abuse during abstinence.
    Chrostek L; Cylwik B; Szmitkowski M; Korcz W
    Clin Chim Acta; 2006 Feb; 364(1-2):167-71. PubMed ID: 16087169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome.
    Krampe H; Stawicki S; Wagner T; Bartels C; Aust C; Rüther E; Poser W; Ehrenreich H
    Alcohol Clin Exp Res; 2006 Jan; 30(1):86-95. PubMed ID: 16433735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the EDAC test to monitor abstinence and relapses during outpatient treatment.
    Harasymiw J; Forster I; Bean P
    J Addict Dis; 2005; 24(3):101-13. PubMed ID: 16186087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative technologies for the diagnosis of alcohol abuse and monitoring abstinence.
    Bean P; Harasymiw J; Peterson CM; Javors M
    Alcohol Clin Exp Res; 2001 Feb; 25(2):309-16. PubMed ID: 11236848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of carbohydrate-deficient transferrin in alcohol-elated problems].
    Rubio Valladolid G; Martínez Ruiz M
    An Med Interna; 1997 Sep; 14(9):473-7. PubMed ID: 9453759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of contemporary biomarkers in the detection of chronic alcohol use.
    Montalto NJ; Bean P
    Med Sci Monit; 2003 Dec; 9(12):RA285-90. PubMed ID: 14646983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic tests of alcohol consumption].
    Chrostek L; Szmitkowski M
    Pol Merkur Lekarski; 2002 Aug; 13(74):154-7. PubMed ID: 12420351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CDT: a biological marker of alcohol abuse].
    Crespi V; Andreotta U; Tettamanzi E; Ferrario MM
    Med Lav; 2007; 98(6):466-74. PubMed ID: 18041466
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.